ORYZON Reports Results and Corporate Update for Quarter
Oryzon invests $4.2 million in R&D in the first quarter 2022...
Stay updated with breaking news from Recent Highlights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Oryzon invests $4.2 million in R&D in the first quarter 2022...
Initial Data from REDWOOD-HCM OLE, the Open Label Extension Study of Aficamten, to be Presented at Heart Failure 2022 on May 23, 2022 Continued Launch...
Global Cancer immunotherapy MKT to reach 152B by 2024 led by Astra Zeneca: AZN; Celgene: CELG Including Late Stage Newcomer; Citius Pharmaceuticals NASDAQ: CTXR
/PRNewswire/ -- Caesars Entertainment, Inc., (NASDAQ: CZR) ("Caesars," "CZR," "CEI" or "the Company") today reported operating results for the first quarter...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.